Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus
Creator
Wang, Xiao
Chen, Yong
Liu, Jun
Li, Na
Wang, X
Liang, Jing
Chen, Y
Liu, J
Shao, J
Tang, Min
Liang, J
Li, N
Li, ,na
Shao, Jiaqing
Tang, M
Ye, Bo
Ye, B
source
Elsevier; Medline; PMC
abstract
AIMS: Coronavirus disease (COVID-19), also referred to as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is instigated by a novel coronavirus. The disease was initially reported in Wuhan, China, in December 2019. Diabetes is a risk factor associated with adverse outcomes. Herein, our objective was to investigate the characteristics of laboratory findings of type 2 diabetes mellitus (T2DM) patients infected with SARS-CoV-2. METHODS: This was a retrospective study and included 80 T2DM patients of Jinling Hospital from 2010–2020, as well as 76 COVID-19 patients without T2DM and 55 COVID-19 patients with T2DM who were treated at Huoshen hill Hospital from February 11 to March 18, 2020. We then compared the differences in laboratory test results between the three groups. RESULTS: The levels of lymphocytes, uric acid (UA), and globulin in the T2DM group were significantly higher. In contrast, C-reactive protein (CRP), creatinine, and lactic dehydrogenase (LDH)levels were lower than those in the COVID-19 (p < 0.05) and COVID-19 + T2DM groups (p < 0.05). No considerable difference was observed regarding the levels of alanine aminotransferase (ALT), white blood cell (WBC), aspartate aminotransferase (AST), globulin, and blood urea nitrogen (BUN) in the three groups (p>0.05). CONCLUSION: T2DM patients infected with SARS-CoV-2 showed decreased levels of body mass index (BMI), lymphocytes, UA, and albumin, and increased CRP levels. The decreased BMI, UA, and albumin levels may be associated with oxidative stress response and nutritional consumption. The decreased lymphocyte counts and increased CRP levels may be related to the infection.
has issue date
2020-07-22
(
xsd:dateTime
)
bibo:doi
10.1016/j.diabres.2020.108351
bibo:pmid
32711001
has license
no-cc
sha1sum (hex)
77297012bfd2c7cb4d03770181e12aa1c1c27cd4
schema:url
https://doi.org/10.1016/j.diabres.2020.108351
resource representing a document's title
Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus
has PubMed Central identifier
PMC7375292
has PubMed identifier
32711001
schema:publication
Diabetes Res Clin Pract
resource representing a document's body
covid:77297012bfd2c7cb4d03770181e12aa1c1c27cd4#body_text
is
schema:about
of
named entity 'patients'
named entity 'disease'
named entity 'infected'
named entity 'CHARACTERISTICS'
named entity 'REFERRED TO'
named entity 'DISEASE'
named entity 'Coronavirus'
named entity 'referred'
named entity 'COVID-19'
named entity 'Characteristics'
named entity 'Coronavirus disease'
named entity 'CRP'
named entity 'signs and symptoms'
named entity 'Diabetes'
named entity 'China'
named entity 'metabolic'
named entity 'T2DM'
named entity 'DBP'
named entity 'Albumin'
named entity 'COVID-19'
named entity 'T2DM'
named entity 'food consumption'
named entity 'chi-square test'
named entity 'T2DM'
named entity 'T2DM'
named entity 'COVID-19'
named entity 'ROS'
named entity 'comorbidities'
named entity 'free radicals'
named entity 'lymphocytes'
named entity 'T2DM'
named entity 'BMI'
named entity 'T2DM'
named entity 'T2DM'
named entity 'oxidative stress'
named entity 'reactive oxygen species'
named entity 'antioxidant'
named entity 'malnutrition'
named entity 'superoxide'
named entity 'SBP'
named entity 'Laboratory tests'
named entity 'antioxidants'
named entity 'enzyme'
named entity 'BMI'
named entity 'Diastolic blood pressure'
named entity 'plasma'
named entity 'albumin'
named entity 'BMI'
named entity 'national health commission'
named entity 'antioxidant'
named entity 'SPSS'
named entity 'COVID'
named entity 'inflammation'
named entity 'nutritional status'
named entity 'COVID'
named entity 'ROS'
named entity 'mmol/L'
named entity 'pulmonary disease'
named entity 'physiological'
named entity 'T2DM'
named entity 'creatinine levels'
named entity 'COVID'
named entity 'BMI'
named entity 'BMI'
named entity 'confounding'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 5
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software